Table 1. Clinical details of amblyopic subjects.
| Refraction | Visual Acuity (VA) | ||||||
| Subject | Age/Gender | RE | LE | RE | LE | Interocular VA (logMAR) | Squint |
| A1 | 32/F | −0.5 | +0.5/+1.75 129° | 20/12.5 | 20/80 | 0.8 | ø |
| A2 | 25/F | −0.25/−0.5 135° | +3.75/+2.25 155° | 20/16 | 20/80 | 0.7 | ø |
| A3 | 20/F | +1.75/+1.25 101° | −1.0/+0.75 82° | 20/80 | 20/20 | 0.6 | ø |
| A4 | 36/M | plano | +2.5 | 20/12.5 | 20/63 | 0.7 | ø |
| A5 | 24/M | −0.25/−1.75 97° | −3.0/−0.75 73° | 20/80 | 20/16 | 0.7 | ø |
| S1 | 38/F | +1.5/+1.75 91° | +2.5/+1.0 84° | 20/20 | 20/40 | 0.3 | ø |
| S2 | 34/F | +0.25/−0.25 12° | plano/−0.75 178° | 20/63 | 20/12.5 | 0.7 | D14Δ, N10Δ ET |
| S3 | 34/F | +1.25/−1.5 53° | +0.25/+0.25 62° | 20/100 | 20/20 | 0.7 | N = D10Δ ET |
| S4 | 29/F | −0.5 | plano/−0.5 132° | 20/16 | 20/40 | 0.4 | ø |
| S5 | 22/M | −3.75/+3.5 159° | −2.25/+2.0 130° | 20/20 | 20/32 | 0.2 | ø |
| S6 | 22/M | +0.25 | −0.25/−0.5 58° | 20/80 | 20/10 | 0.9 | D12Δ, N8Δ XT |
| S7 | 39/M | +1.25/−1.25 11° | +0.5/+1.5 95° | 20/12.5 | 20/25 | 0.3 | D8Δ, N8Δ ET |
| S8 | 23/M | +1.5/+1.25 100° | +2.75/+0.5 63° | 20/40 | 20/12.5 | 0.5 | D = N40Δ XT |
| S9 | 25/F | −4.25/−0.5 16° | −4.5/−0.75 176° | 20/20 | 20/32 | 0.2 | D = N25Δ XT |
| SA1 | 40/F | +1.75 | +3.5 | 20/12.5 | 20/50 | 0.6 | ø |
| SA2 | 46/F | −1.5/−1.0 140° | +0.25/−1.75 19° | 20/20 | 20/125 | 0.8 | D18Δ, N25Δ ET |
| SA3 | 22/M | +1.5 | +3.0/+0.5 75° | 20/10 | 20/63 | 0.8 | D4Δ, N6Δ ET |
| SA4 | 24/M | +2.25/+1.0 177° | +3.75/+1.75 117° | 20/16 | 20/32 | 0.3 | D25Δ, N20Δ XT |
A: anisometropic, S: strabismic, SA: strabismic & anisometropic, RE: right eye, LE: left eye, VA: visual acuity, D: distant, N: near, ET: esotropia, XT: exotropia. Patients listed as strabismics and having no squint angle, have been operated on after developing amblyopia.